Cargando…
The DC–T cell axis is an effective target for the treatment of non‐small cell lung cancer
The dendritic cell (DC)‐T cell axis is a bridge that connects innate and adaptive immunities. The initial immune response against tumors is mainly induced by mature antigen‐presenting DCs. Enhancing the crosstalk between DCs and T cells may be an effective approach to improve the immune response to...
Autores principales: | Wang, Shuangcui, Zhang, Guan, Cui, Qian, Yang, Yanjie, Wang, Dong, Liu, Aqing, Xia, Ying, Li, Wentao, Liu, Yunhe, Yu, Jianchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681037/ https://www.ncbi.nlm.nih.gov/pubmed/38018578 http://dx.doi.org/10.1002/iid3.1099 |
Ejemplares similares
-
Prognostic significance of blood-based PD-L1 analysis in patients with non-small cell lung cancer undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis
por: Cui, Qian, et al.
Publicado: (2023) -
Clinical predictive value of naïve and memory T cells in advanced NSCLC
por: Zhang, Guan, et al.
Publicado: (2022) -
The clinical value of the changes of peripheral lymphocyte subsets absolute counts in patients with non-small cell lung cancer
por: Xia, Ying, et al.
Publicado: (2020) -
The Predictive Value of Changes in the Absolute Counts of Peripheral Lymphocyte Subsets for Progression and Prognosis in Breast Cancer Patients
por: Liu, Aqing, et al.
Publicado: (2022) -
Hsa_Circ_0001947/MiR-661/DOK7 Axis Restrains Non-Small Cell Lung Cancer Development
por: Bao, Yuyan, et al.
Publicado: (2021)